期刊文献+

尘肺并发结核患者耐多药结核分枝杆菌L型异烟肼耐药基因katG序列突变特点分析 被引量:1

Analysis on the mutational characteristics of isoniazid-resistant gene katG sequence in MDR-MTB L-form from the patients with pneumoconiosis and tuberculosis
在线阅读 下载PDF
导出
摘要 目的探讨淮南矿区尘肺并发结核患者感染耐多药结核分枝杆菌(multiple drugs resistant Mycobacterium tuberculosis,MDR-MTB)L型异烟肼耐药基因katG突变特点。方法收集114株MTB菌L型临床分离株,用药敏试验鉴定MDR-MTB菌L型;抽提MDR-MTB L型和H37Rv标准菌株DNA,PCR法扩增katG基因,并对katG基因的突变集中区域进行测序分析。结果从114株临床分离株中检出MDR-MTB菌L型31株(27.2%),其katG基因突变率为61.3%(19/31);主要集中在315位点碱基置换突变,以Ser315Thr为主(AGC→ACC)(48.4%,15/31),其次是315位点Ser315Asn(AGC→AAC)突变(9.7%,3/31)以及431位点Ala431Val(GCG→GTG)突变(3.2%,1/31),未发现多位点联合突变,12株(38.7%,12/31)未发现katG基因突变;随机检测的10株异烟肼敏感株未见katG基因单链构象异常。结论淮南矿区尘肺并发结核患者感染的MDR-MTB菌L型异烟肼耐药情况较为严重,高度保守的katG基因突变是导致异烟肼耐药的分子基础,其突变位点呈多样性。 Objective To investigate the mutational characteristics of isoniazid-resistant gene katG in multiple drugs resistant Mycobacterium tuberculosis (MDR-MTB) L-form from the patients with pneumoconiosis and tuberculosis in Huainan mining district. Methods A total of 114 clinical isolates of MTB L-form were collected, and MDR-MTB were identified by the conventional antimicrobial susceptibility test (AST). The genome DNA from MDR-MTB L-form and standard strain H37Rv was extracted, and the katG gene was amplified by PCR. Then, the hot mutation regions in katG gene were analyzed by direct sequencing. Results Thirty-one (27.2%) MDR-MTB L-form strains were detected from 114 clinical isolates, and the mutation rate of katG gene was 61.3% ( 19/31 ). The mutation sites were mainly located on codon 315, including Ser315Thr (AGC→ACC, 15/31,48.4% ) and Ser315Asn (AGC→AAC, 3/ 31, 9.7% ) , and codon 431 (Ala431Val, GCG→GTG, 1/31, 3.2% ). No multisite mutation was found. Moreover, no single strand conformation abnormity of katG gene was found in randomly collected 10 isoniazid-sensitive strains. Conclusion There was serious isoniazid-resistance of MDR-MTB L-form in the patients with pneumoconiosis and tuberculosis in Huainan mining district. The mutation of highly conserved katG gene was responsible for isoniazid-resistance of MDR-MTB L-form, and there were diversiform mutation sites.
出处 《临床检验杂志》 CAS CSCD 北大核心 2013年第6期434-437,共4页 Chinese Journal of Clinical Laboratory Science
基金 国家自然科学基金(81172778) 安徽省高校省级重点自然科学研究项目(KJ2010A087 KJ2012A081) 2011年淮南市科技计划项目(2011A07902) 2011年安徽理工大学中青年学术骨干基金
关键词 尘肺 结核 耐多药结核分枝杆菌L型 耐药 KATG基因 序列分析 pneumoconiosis tuberculosis multiple drugs resistant Mycobacterium tuberculosis L-form drug-resistance katG gene sequence analysis
作者简介 陆军,1972年生,男,副教授,硕士研究生导师,博士研究生,主要从事病原生物学检验、环境污染与人类健康等研究。 通信作者:李朝品,教授,博士研究生导师,E-mail:epli001@126.com。
  • 相关文献

参考文献8

二级参考文献28

  • 1乐军,曾而良,谢建平,李瑶,梁莉,王洪海.中国耐多药结核分枝杆菌临床分离株rpoB基因突变特点[J].Acta Genetica Sinica,2004,31(12):1332-1336. 被引量:23
  • 2李凫坚,李锋,李君.结核分枝杆菌rpoB基因突变特征的初步探讨[J].中国防痨杂志,2006,28(5):285-287. 被引量:5
  • 3刘敬华,张丽水,刘志广,黄明翔,赵秀芹,王琳,万康林.结核分枝杆菌利福平耐药基因rpoB突变特征初步分析[J].中华流行病学杂志,2006,27(11):973-976. 被引量:22
  • 4中国疾病预防控制中心.中国结核病防治规划实施工作指南.北京:卫生部医政司,2008:3-4.
  • 5世界卫生组织结核病研究培训中心.耐药结核病规划管理指南.WHO出版社,2008:1-31.
  • 6深圳市结核病控制项目实施工作指南.2版.深圳市结核病控制项目领导小组办公室,2008:1-3.
  • 7Tracevsk T,Jansone I,Broka L,et al.Mutations in the rpoB and katG genes leading to drug resistance in Mycobacterium tuberculosis in Latvia.J Clin Microbiol,2002,40(10):3789-3792.
  • 8Sreevatsan S,Pan X,Stockbauer KE,et al.Characterization of rpsL and rrs mutations in streptomycin-resistant Mycobacterium tuberculosis isolates from diverse geographic localities.Antimicrobial Agents and Chemotherapy,1996,40(4):1024-1026.
  • 9Suzuki Y,Katsukawa C,Tamaru A,et al.Detection of kanamycin-resistant Mycobacterium tuberculosis by indentifying mutations in the 16s RNA gene.J Clin Microbiol,1998,36(5):1220-1225.
  • 10Shi B,zhang J,Li C,et al.Emergence of ofloxacin resistance in Mycobacterium tuberculosis clinical isolates from China as determined by gyrA mutation analysis using denaturing high-pressure liquid chromatography and DNA sequencing.J Clin Microbiol,2006,44(12):4566-4568.

共引文献97

同被引文献51

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部